SCHEMBL17876512

SCHEMBL17876512

Clc1ccc(-c2cccc(-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTRC Q99895 1/20 0.61
MEN1 O00255 7/20 0.55
KMT2A Q03164 7/20 0.55
ALDH1A1 P00352 6/20 0.55
HPGD P15428 5/20 0.55
L3MBTL1 Q9Y468 4/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
MAPT P10636 4/20 0.54
KDM4E B2RXH2 4/20 0.54
LMNA P02545 3/20 0.54
CYP1A2 P05177 1/20 0.54
NTSR1 P30989 1/20 0.53
ADORA3 P0DMS8 1/20 0.51
TDP1 Q9NUW8 1/20 0.50
GLA P06280 1/20 0.50
MAOB P27338 1/20 0.49
ALDH1A3 P47895 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
ADORA2A P29274 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20932484 1.00 CTRC (0.61) CTRCMEN1KMT2AALDH1A1HPGD
SCHEMBL21689700 1.00 CTRC (0.61) CTRCMEN1KMT2AALDH1A1HPGD
SCHEMBL23419405 0.98 CTRC (0.59) CTRCMEN1KMT2AALDH1A1HPGD
SCHEMBL30775134 0.95 CTRC (0.59) CTRCMEN1KMT2AALDH1A1HPGD
SCHEMBL22582682 0.95 CTRC (0.59) CTRCMEN1KMT2AALDH1A1HPGD
SCHEMBL30496807 0.95 CTRC (0.59) CTRCMEN1KMT2AALDH1A1HPGD
SCHEMBL30565762 0.95 CTRC (0.59) CTRCMEN1KMT2AALDH1A1HPGD
SCHEMBL23419096 0.95 CTRC (0.59) CTRCMEN1KMT2AALDH1A1HPGD
SCHEMBL17870904 0.95 CTRC (0.59) CTRCMEN1KMT2AALDH1A1HPGD
SCHEMBL25824721 0.95 CTRC (0.59) CTRCMEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230045312-A1 AN ORGANIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-02-09 US disclosed
WO-2021101255-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME 솔루스첨단소재 주식회사 2021-05-27 WO disclosed
WO-2016105072-A2 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME 주식회사 두산 2016-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230045312-A1 AN ORGANIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME SLCO4C1, SLC25A21, SLCO2A1 CTRC 1922/4885MEN1 2533/4885KMT2A 3468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.